Abstract:Bacteria have been extensively utilized as living therapeutics for disease treatment due to their unique characteristics, such as genetic manipulability, rapid proliferation and specificity to target disease sites. Various in vivo insults can, however, decrease the vitality of dosed bacteria, leading to low overall bioavailability. Additionally, the innate antigens on the bacterial surface and the released toxins and metabolites may cause undesired safety issues. These limitations inevitably result in inadequate treatment outcomes, thereby hindering the clinical transformation of living bacterial therapeutics. Recently, we have developed a versatile platform to prepare advanced living bacterial therapeutics by nanocoating bacteria individually via either chemical decoration or physical encapsulation, which can improve bioavailability and reduce side effects for enhanced microbial therapy. Here we use interfacial self-assembly to prepare lipid membrane-coated bacteria (LCB), exhibiting increased resistance against a variety of harsh environmental conditions owing to the nanocoating's protective capability. Meanwhile, we apply mechanical extrusion to generate cell membrane-coated bacteria (CMCB), displaying improved biocompatibility owing to the nanocoating's shielding effect. We describe their detailed preparation procedures and demonstrate the expected functions of the coated bacteria. We also show that following oral delivery and intravenous injection in mouse models, LCB and CMCB present appealing potential for treating colitis and tumors, respectively. Compared with bioengineering that lacks versatile molecular tools for heterogeneous expression, the surface nanocoating technique is convenient to introduce functional components without restriction on bacterial strain types. Excluding bacterial culture, the fabrication of LCB takes ~2 h, while the preparation of CMCB takes ~5 h.

Dopamine Polymerization-Mediated Surface Functionalization toward Advanced Bacterial Therapeutics

Self-polymerization-adhesion Behavior of Dopamine and Surface Functionalization of Membranes

Polymeric Nanoplatforms for the Delivery of Antibacterial Agents

Biopolymer Coating for Particle Surface Engineering and Their Biomedical Applications

Surface-modified bacteria: synthesis, functionalization and biomedical applications

Targeted polymer-based antibiotic delivery system: A promising option for treating bacterial infections via macromolecular approaches

Polydopamine, harness of the antibacterial potentials-A review

Dopamine-Triggered One-Step Polymerization and Codeposition of Acrylate Monomers for Functional Coatings

Enzymatically Activatable Polymers for Disease Diagnosis and Treatment

Bioorthogonal Functionalization of Material Surfaces with Bioactive Molecules

Functionalization of Polymers and Nanomaterials for Biomedical Applications: Antimicrobial Platforms and Drug Carriers

The Mechanisms and the Applications of Antibacterial Polymers in Surface Modification on Medical Devices

Surface nanocoating of bacteria as a versatile platform to develop living therapeutics

Versatile Polydopamine Platforms: Synthesis and Promising Applications for Surface Modification and Advanced Nanomedicine

Bacteria/Nanozyme Composites: New Therapeutics for Disease Treatment

Antimicrobial and antifouling surfaces through polydopamine bio-inspired coating

Translating bacteriophage-derived depolymerases into antibacterial therapeutics: Challenges and prospects

Functional Modification of Bacteria during Plasmolysis and Deplasmolysis for Tumor Diagnosis and Treatment

A versatile ethanol-mediated polymerization of dopamine for efficient surface modification and the construction of functional core-shell nanostructures

Exploring the Complex Impact of Proteins on Dopamine Polymerization: Mechanisms and Strategies for Modulation

Functionalization of Polymers for Intracellular Protein Delivery